Business Context and Reporting Period
Zurn Elkay Water Solutions Corp (ZWS) filed its Form 10-Q for the quarter ended March 31, 2025. The company is a growth-oriented, pure-play water management business operating as a single reportable segment. It designs, manufactures, and markets specification-driven water management solutions, including water safety, flow systems, and filtered drinking water products.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $388.8 million | $373.8 million |
| Gross Profit | $181.0 million | $170.1 million |
| Income from Operations | $63.4 million | $53.2 million |
| Net Income | $43.6 million | $34.3 million |
| Diluted EPS | $0.26 | $0.19 |
| Operating Cash Flow | $42.9 million | $53.9 million |
| Cash and Equivalents | $144.7 million | $157.1 million |
| Total Debt | $495.8 million | $495.6 million |
| Adjusted EBITDA | $98.0 million | $90.0 million |
Margins: Operating margin improved to 16.3% in Q1 2025 from 14.2% in Q1 2024. The effective income tax rate was 26.9% compared to 20.9% in the prior year.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4.0% year-over-year, driven by a 5% increase in core sales volume. Foreign currency exchange rates reduced net sales by approximately 1%.
- Profitability: Income from operations rose 19.2% to $63.4 million, aided by productivity initiatives, lower restructuring charges ($1.7 million vs. $6.3 million), and synergy benefits.
- Interest Expense: Net interest expense decreased to $7.3 million from $8.8 million due to lower interest rates.
- Discontinued Operations: Income from discontinued operations (related to the 2021 spin-off of the Process & Motion Control business) increased to $2.6 million from $0.3 million, primarily due to the release of accruals.
- Share Repurchases: The company significantly increased buyback activity, repurchasing $77.4 million of stock in Q1 2025 compared to $18.9 million in Q1 2024.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted that core sales improved across all product categories. The company continues to execute restructuring actions to optimize operating margins and manufacturing footprints, expecting further expenses related to workforce reductions and facility rationalization.
Backlog: As of March 31, 2025, backlog stood at $72.3 million, with the company expecting to recognize approximately 100% of this amount in the remaining nine months of 2025.
Debt Covenants: The company remains in compliance with its credit agreement. The Net First Lien Leverage Ratio was 0.98 to 1.00 as of March 31, 2025, well below the maximum covenant limit of 5.00 to 1.00.
Risks and Contingencies:
- Restructuring: Future restructuring costs are not yet fully estimable.
- Tax Rates: The effective tax rate exceeded the statutory rate due to compensation deduction limitations and foreign/state taxes.
- Legal: The company is involved in various ordinary course legal actions, though management does not expect a material adverse effect.
Investor Verification Checklist
- Verify the sustainability of the 5% core sales growth given the 1% headwind from foreign currency.
- Monitor the trajectory of restructuring charges, as management expects further expenses in future periods.
- Review the impact of the increased effective tax rate (26.9%) on future net income projections.
- Assess the pace of share repurchases ($77.4M in Q1) against the remaining $162.8M authorization.
- Confirm the realization of the $72.3 million backlog within the expected timeframe.